Genetic testing industry news
Funding rounds, product launches, research findings, and policy updates — published 3× per week.
IndustryGRAIL's Galleri Multi-Cancer Early Detection Test Advances Toward Broader Medicare Coverage
GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.
2026-06-23
ProductNeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
NeoGenomics debuts an FDA-approved PTEN IHC companion diagnostic, expanding precision oncology options for prostate cancer patients.
2026-07-10
ProductGuardant Health's Guardant360 Liquid CDx Earns FDA Approval with 100x Expanded Panel Footprint
FDA approves the new Guardant360 Liquid CDx as the largest FDA-approved liquid biopsy panel, dramatically expanding its genomic coverage.
2026-07-08
IndustryDNA Diagnostics Market Projected to Hit $24.7 Billion by 2034 as Precision Medicine Drives Global Demand
The global DNA diagnostics market is forecast to reach $24.7B by 2034, fueled by precision medicine adoption and rapid genomic advancements.
2026-07-07
Sponsored content
Reach genetic testing decision-makers with your story
Sponsored articles appear in the News feed and the weekly newsletter. $500/article.